Although cell-free DNA (cfDNA) is an emerging sepsis biomarker, the use of cfDNA,
especially as diagnostic and prognostic indicators, has surprisingly not been systemically …

Background Sepsis is one of the most common diseases that seriously threaten human
health. Although a large number of markers related to sepsis have been reported in the last …

Differentiating between sepsis and non-infectious systemic inflammatory response
syndrome (SIRS) poses a great challenge. Several potential bloodstream biomarkers …

Background The definition of sepsis has evolved over time, along with the clinical and
scientific knowledge behind it. For years, sepsis was defined as a systemic inflammatory …

Background Numerous studies have shown that cell-free DNA (cfDNA) levels may serve as
a non-invasive biomarker of a broad spectrum of acute and chronic pathologies. However, in …

High-quality biomarkers that detect emergent graft damage and/or rejection after solid-organ
transplantation offer new opportunities to improve post-transplant monitoring, allow early …

Lupus nephritis (LN) is a severe renal disease caused by the massive deposition of the
immune complexes (ICs) in renal tissue, acting as one of the significant organ …

Background The definition of sepsis has evolved over time, along with the clinical and
scientific knowledge behind it. For years, sepsis was defined as a systemic inflammatory …

Aim To evaluate the correlation between circulating cell‐free DNA (ccfDNA) in plasma and
clinical disease activities in patients with rheumatoid arthritis (RA). Method The study group …

Atherosclerosis (AS) is the leading cause of cardiovascular diseases (CVDs) with a high rate
of mortality worldwide. Plasma cell-free DNA (cfDNA), mainly originating from apoptosis …